Table 5 KEGG Pathway enrichment analysis results
KEGG ID | Pathway Name | P-value |
|---|---|---|
KEGG Pathways mediated by upregulated genes | ||
path:05219 | Bladder cancer | 0.000 |
path:05144 | Malaria | 0.000 |
path:04115 | p53 signaling pathway | 0.000 |
path:05140 | Leishmaniasis | 0.001 |
path:05164 | Influenza A | 0.001 |
path:05323 | Rheumatoid arthritis | 0.001 |
path:04620 | Toll-like receptor signaling pathway | 0.001 |
path:05142 | Chagas disease (American trypanosomiasis) | 0.001 |
path:04145 | Phagosome | 0.005 |
path:05200 | Pathways in cancer | 0.005 |
path:04621 | NOD-like receptor signaling pathway | 0.007 |
path:04622 | RIG-I-like receptor signaling pathway | 0.010 |
path:04010 | MAPK signaling pathway | 0.021 |
path:05146 | Amoebiasis | 0.022 |
path:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 0.032 |
path:05162 | Measles | 0.034 |
path:05160 | Hepatitis C | 0.034 |
KEGG Pathways mediated by downregulated genes | ||
path:04380 | Osteoclast differentiation | 0.016 |
path:00760 | Nicotinate and nicotinamide metabolism | 0.037 |